These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7639084)

  • 1. Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment.
    Sharma RP; Faull K; Javaid JI; Davis JM
    Acta Psychiatr Scand; 1995 May; 91(5):293-8. PubMed ID: 7639084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF phenylacetic acid and hostility in paranoid schizophrenia.
    Faull KF; King RJ; Barchas JD; Csernansky JG
    Psychiatry Res; 1989 Nov; 30(2):111-8. PubMed ID: 2616681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of phenylacetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry.
    Kawabata M; Kobayashi K; Shohmori T
    Acta Med Okayama; 1986 Oct; 40(5):271-6. PubMed ID: 3788666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Karoum F; Potkin S; Chuang LW; Murphy DL; Liebowitz MR; Wyatt RJ
    Biol Psychiatry; 1984 Feb; 19(2):165-78. PubMed ID: 6713036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients.
    Bowers MB; Heninger GR; Gerbode F
    Int J Neuropharmacol; 1969 May; 8(3):255-62. PubMed ID: 5796265
    [No Abstract]   [Full Text] [Related]  

  • 7. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depression.
    Davis BA; Boulton AA; Yu PH; Durden DA; Keegan DL; Bowen RC; Blackshaw S; D'Arcy C; Remillard AJ; Dayal N
    Biol Psychiatry; 1991 Sep; 30(6):600-8. PubMed ID: 1932407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and cerebrospinal fluid concentration of phenylacetic acid in humans and monkeys.
    Karoum F; Chuang LW; Mosnaim AD; Staub RA; Wyatt RJ
    J Chromatogr Sci; 1983 Dec; 21(12):546-50. PubMed ID: 6420430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylacetic acid in CSF and serum in Indian schizophrenic patients.
    Davis BA; Shrikhande S; Paralikar VP; Hirsch SR; Durden DA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):41-7. PubMed ID: 2008539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness.
    Sandler M; Ruthven CR; Goodwin BL; Coppen A
    Clin Chim Acta; 1979 Apr; 93(1):169-71. PubMed ID: 436296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa.
    Davis BA; Kennedy SH; D'Souza J; Durden DA; Goldbloom DS; Boulton AA
    J Psychiatry Neurosci; 1994 Jul; 19(4):282-8. PubMed ID: 7918350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history and CSF homovanillic acid pattern during neuroleptic treatment.
    Bowers MB
    Am J Psychiatry; 1984 Feb; 141(2):296-8. PubMed ID: 6140868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance.
    Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer HY
    Biol Psychiatry; 1997 Mar; 41(5):560-6. PubMed ID: 9046988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate in schizophrenics and healthy controls.
    Gattaz WF; Gattaz D; Beckmann H
    Arch Psychiatr Nervenkr (1970); 1982; 231(3):221-5. PubMed ID: 6123303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects.
    Angrist B; Rotrosen J; Gershon S
    Psychopharmacology (Berl); 1980 Jan; 67(1):31-8. PubMed ID: 6102776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.